Acute Ischemic Stroke (AIS) Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Stroke

Pooja salve

Acute Ischemic Stroke (AIS) Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Stroke

The global Acute Ischemic Stroke (AIS) Market is estimated to be valued at US$ 8,517.0 Million in 2021 and is expected to exhibit a CAGR of 4.0% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The Acute Ischemic Stroke (AIS) Market refers to the market for drugs and devices used in the treatment of acute ischemic stroke, which is caused by a sudden blockage of blood flow to the brain. This market offers various products such as thrombolytic drugs, clot retrieval devices, and neuroprotective agents. These products provide crucial advantages in treating acute ischemic stroke, such as improving blood flow and reducing the risk of disability or death. With the increasing prevalence of stroke worldwide, the demand for effective treatments for AIS is growing rapidly.

Market Key Trends:

One key trend in the Acute Ischemic Stroke (AIS) Market is the development of advanced neuroprotective agents. These agents are designed to protect brain tissues from damage caused by stroke and prevent further neurological deterioration. They work by inhibiting inflammatory processes, reducing oxidative stress, and promoting cell survival. The development of novel neuroprotective agents is a significant trend in the market, as they have the potential to improve patient outcomes and reduce the long-term disability associated with acute ischemic stroke.

PEST Analysis

Political: The political factors influencing the acute ischemic stroke (AIS) market include government regulations, healthcare policies, and funding for research and development. Governments play a crucial role in shaping the healthcare landscape and policies related to stroke prevention, treatment, and rehabilitation. For example, government initiatives to improve stroke awareness and provide affordable access to stroke care can positively impact the market.

Economic: The economic factors impacting the AIS market include healthcare expenditure, insurance coverage, and the overall economic condition of countries. As the prevalence of stroke continues to rise globally, healthcare expenditure is expected to increase, driving the demand for AIS treatments. Economic growth and development can also lead to improved healthcare infrastructure and affordability, further driving market growth.

Social: The social factors influencing the AIS market include demographic trends, lifestyle choices, and public awareness of stroke prevention and treatment. Aging populations, unhealthy lifestyles, and an increase in risk factors such as diabetes and hypertension contribute to the rising prevalence of stroke. However, increasing awareness of stroke symptoms and the importance of early intervention can drive the demand for AIS treatments.

Technological: The technological factors impacting the AIS market include advancements in diagnostic tools, medical devices, and telemedicine solutions. Continuous research and development in stroke treatment options, such as thrombectomy devices and clot-busting drugs, are driving advancements in the field. Moreover, the integration of technology into stroke care, such as remote monitoring and tele-rehabilitation, is transforming post-stroke patient management.

Key Takeaways

The Global Acute Ischemic Stroke (AIS) Market Demand is expected to witness high growth, exhibiting a CAGR of 4.0% over the forecast period of 2021-2028. This growth can be attributed to several factors, including the increasing prevalence of stroke, government initiatives to improve stroke care, and advancements in stroke treatment technologies.

In terms of regional analysis, North America is projected to be the fastest-growing and dominating region in the AIS market. The region's well-established healthcare infrastructure, high healthcare expenditure, growing geriatric population, and favorable government healthcare policies contribute to its market dominance.

Key players operating in the AIS market include F. Hoffmann-La Roche AG, Boehringer Ingelheim, Bayer AG, Pfizer Inc., Biogen, Daiichi Sankyo, Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca, SanBio, and Athersys Inc. These companies are actively involved in research and development activities, strategic collaborations, and product launches to gain a competitive edge in the market.

In conclusion, the global AIS market is expected to have significant growth potential fueled by political initiatives, economic factors, societal changes, and technological advancements. The dominance of North America and the presence of key players further contribute to the market's growth and competitiveness.

Pooja salve

Medical Devices For Acute Ischemic Stroke is Estimated to Witness High Growth Owing to Opportunity of Increasing Number of Stroke Patients

Alex Huge 2024-01-05

Acute ischemic stroke (AIS) occurs due to blockage of blood flow to the brain, often caused by blood clots or thrombi. This growing patient population will propel the demand for effective AIS treatment devices such as stent retrievers globally. SWOT Analysis Strength: High unmet medical needs, increasing awareness, favorable regulatory environment and reimbursement schemes drive the market growth. Weakness: Underdeveloped healthcare infrastructure and access in developing economies, high treatment cost, risk of recurrent strokes. Key Takeaways The global Acute Ischemic Stroke (AIS) market size is expected to witness high growth during the forecast period owing to rising incidence of strokes worldwide.

Tissue Plasminogen Activator Therapy is Estimated to Witness High Growth Owing to Opportunity in Neurovascular Conditions Management

Sumedha 2024-01-05

Tissue plasminogen activator (tPA) therapy aims to treat AIS by dissolving clots through fibrinolytic medications that help break down blood clots. Bargaining power of buyers: The bargaining power of buyers is high as buyers have many treatment options available. Threat of new substitutes: The threat of new substitutes is high as new treatment methods, drugs and other alternatives constantly enter the market. Key Takeaways The Global Acute Ischemic Stroke (AIS) Market Size is expected to witness high growth during the forecast period of 2023 to 2030. Key players Key players operating in the AIS market are Boehringer Ingelheim, Daiichi Sankyo, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson.

The Global Acute Ischemic Stroke Market Is Driven By Growing Geriatric Population

Sneha 2024-03-01

The Global Acute Ischemic Stroke (AIS) Market primarily deals with providing diagnostic and therapeutic solutions for patients suffering from acute ischemic stroke. The Global AIS Market is estimated to be valued at US$ 10612. Key TakeawaysKey players operating in the Acute Ischemic Stroke market are F. The market players need to closely monitor the geopolitical changes and Devise contingency plans to minimize supply disruptions. Get more insights on Acute Ischemic Stroke Market

Acute Ischemic Stroke Diagnosis Market Trends, Segmentation, Overview, And Forecast Till 2032

Shraddha 2023-09-29

The Business Research Company’s Acute Ischemic Stroke Diagnosis Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The Acute Ischemic Stroke Diagnosis Global Market Report 2023 evaluates acute ischemic stroke diagnosis market size, growth rate, drivers, trends, and major companies. id=12150&type=smp The global acute ischemic stroke diagnosis market is expected to grow from $1. The acute ischemic stroke diagnosis market is expected to reach $2. Key Mergers And Acquisitions In The Acute Ischemic Stroke Diagnosis Market35.

Microvascular Blood Clot Retrieval Devices Market are Set to Witness Significant Growth Owing to Increasing Number of Vascular Surgeries

Pooja salve 2025-02-26

The Global Blood Clot Retrieval Devices Market is estimated to be valued at USD 1. Stryker Corporation leads the market with over 30% market share owing to its diverse product portfolio in clot removal devices. The key opportunities in the microvascular Blood Clot Retrieval Devices Market Growth comprise increasing adoption of minimally invasive surgeries and growing number of endovascular procedures worldwide. This is expected to generate more surgical procedures and drive the need for microvascular clot retrieval devices. Global Analysis Regionally, North America dominates the global market for blood clot retrieval devices currently.

Global Acute Ischemic Stroke Diagnosis and Treatment Market Report, Latest Trends, Industry Opportunity & Forecast to 2032

Mahira Mitra 2024-04-15

The new Acute Ischemic Stroke Diagnosis and Treatment Market report offers a comprehensive study of the current scenario of the market including major market dynamics. Get more information on "Global Acute Ischemic Stroke Diagnosis and Treatment Market Research Report" by requesting FREE Sample Copy at https://www. The growth and trends of acute ischemic stroke diagnosis and treatment industry provide a holistic approach to this study. Browse Global Acute Ischemic Stroke Diagnosis and Treatment Market Research Report with detailed TOC at https://www. Purchase Complete Global Acute Ischemic Stroke Diagnosis and Treatment Market Research Report at https://www.

WHO TO FOLLOW

MORE FROM AUTHOR

Electronic Clinical Outcome Assessment (eCOA) Market to Grow on Mobile Integration

Pooja salve 2025-06-18

Percutaneous Transluminal Angioplasty Balloons Catheter Market to Grow with Innovative Balloon Technologies

Pooja salve 2025-06-18

Patient Lateral Transfer Devices Market to Grow Rapidly Owing to Aging Population

Pooja salve 2025-06-17

Pyrogen Testing Market is Anticipated to Witness High Growth Owing to Stringent Regulatory Compliance

Pooja salve 2025-06-04

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Ischemic Stroke Pipeline Market Estimated to Soar Owing to Innovative Drug Delivery

kislay kumar 2025-05-02

According to CoherentMI, The Global Ischemic Stroke Pipeline Market is estimated to be valued at USD 1. Key TakeawaysKey players operating in the Ischemic Stroke Pipeline Market are- · GNT Pharma· ZZ Biotech LLC· JIXING Pharmaceuticals· AbbVie· Meridigen Biotech Co. Innovative drug delivery systems represent a transformative technological advancement in the ischemic stroke pipeline, aiming to improve therapeutic efficacy, safety, and patient compliance. Current Challenges in the Ischemic Stroke Pipeline IndustryThe industry’s foremost challenge lies in the inherent complexity of stroke pathophysiology. Fastest Growing Region in the Ischemic Stroke Pipeline MarketAsia Pacific has emerged as the fastest-growing region in the ischemic stroke pipeline arena.

Joel Michael Singer | Best Neurosurgeon

Joel Michael Singer 2021-10-20

Joel Michael Singer serves as the Surgical Director of the Neuro-Intensive Care Unit, caring for patients suffering from the acute effects of both hemorrhagic as well as ischemic stroke.

He is an extremely experienced and world-renowned team of critical care and stroke neurologists, as well as interventional radiologists, endovascular neurosurgeons.

Joel Michael provides highly personalized state-of-the-art care for patients with brain aneurysms and spontaneous hemorrhages.

Trends Shaping the Transient Ischemic Attack (TIA) Market

Pragaji Tank 2025-03-06

The transient ischemic attack (TIA) market is experiencing significant shifts due to emerging trends in the healthcare sector. The Global Transient Ischemic Attack Market is estimated to be valued at USD 1. Focus on Early Diagnosis One of the most prominent trends in the TIA market is the growing emphasis on early diagnosis. The combination of increased awareness and better access to healthcare is expected to drive the TIA market’s growth, particularly in emerging economies. The trends shaping the transient ischemic attack market emphasize early diagnosis, preventive treatments, technological advancements in telemedicine, and increasing public awareness.

Marine AIS Monitoring Solution Market Demand Analysis, Statistics, Industry Trends And Investment Opportunities To 2027

Kevin Anderson 2021-06-09

The global Marine AIS Monitoring Solution Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.

Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.

The key players in the marine AIS monitoring solution market include Atlantic Marine Electronics, Caterpillar Inc., Exact Earth, Honeywell, McMurdo Group, Oceaneering International and Teledyne Brown Engineering.

An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Marine AIS Monitoring Solution Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/marine-ais-monitoring-solution-market/download-sampleMarket DynamicsIncreasing maritime traffic owing to rise in marine transport and global trade activities are driving the market growth.

However, risk regarding the security of AIS may hinder the market growth.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.

These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities.

Ischemic stroke market Opportunity, Importance, Status, Latest Advancements Research Report 2019-2023

Rohit Kamble 2020-10-12

Ischemic stroke market research report: by diagnosis (CT, MRI, carotid ultrasound, cerebral angiography), drug class (tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive), surgery, end user – Global forecast till 2023Market Scenario:Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain.

The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.

According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually.

As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.Avail a Free Sample Insights @ https://www.marketresearchfuture.com/sample_request/5423 The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.Some of key the players in the Americas ischemic stroke market are Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and othersSegmentation:The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users.On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and othersOn the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomyOn the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.Browse Complete Premium Research Report@ https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423 Intended Audience:Ischemic Stroke Drug SuppliersIschemic Stroke Drug ManufacturersResearch and Development (R) CompaniesMedical Research LaboratoriesAcademic Medical Institutes and UniversitiesAbout Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:Market Research Future +1 646 845 9312Email: sales@marketresearchfuture.com

Effective Acute Vulvovaginal Candidiasis Treatment: A Comprehensive Guide

Ben Wood 2023-04-28

Acute vulvovaginal candidiasis is a common condition that affects many women worldwide. Fortunately, there are several effective treatment options available to alleviate symptoms and cure the infection. Boric acid suppositories can also be used in combination with Acute Vulvovaginal Candidiasis Treatment to improve the cure rate. Food and Drug Administration) for vulvovaginal candidiasis and the first drug approved in a new antifungal class for vulvovaginal candidiasis in more than 20 years. Some women with infections opt for treatment with over-the-counter (OTC) medications, which generally are highly effective for candidiasis.

Marine AIS Monitoring Solution Market 2021 Major Key Players and Industry Analysis Till 2027

Divyaa Meena 2021-12-22

The key players in the marine AIS monitoring solution market include Atlantic Marine Electronics, Caterpillar Inc. Get more information on "Global Marine AIS Monitoring Solution Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Marine AIS Monitoring Solution Market Research Report with detailed TOC at https://www. By Product· Onshore Based· Vessel BasedBy Application· Fleet Leasing & Fleet Management· Logistics Companies· OthersRegional AnalysisFurthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for marine AIS monitoring solution in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Purchase complete Global Marine AIS Monitoring Solution Market Research Report at https://www.

Global Neuroendovascular Coil Market Report 2020 Forecast to 2025

Sonam Shaha 2020-06-22

The latest trending report Global Neuroendovascular Coil Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.

The report will assist reader with better understanding and decision making.The Neuroendovascular Coil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.This report also researches and evaluates the impact of Covid-19 outbreak on the Neuroendovascular Coil industry, involving potential opportunity and challenges, drivers and risks.

We present the impact assessment of Covid-19 effects on Neuroendovascular Coil and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.

).Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/40676-neuroendovascular-coil-industry-analysis-reportThe major players covered in Neuroendovascular Coil are:StrykerMedtronicCodman (DePuy)MicroVentionPenumbraBy Type, Neuroendovascular Coil market has been segmented intoBare Metal CoilHydrogel Coated CoilsBy Application, Neuroendovascular Coil has been segmented into:Aneurysm-EmbolizationMalformation-EmbolizationIschemic stroke-RevascularizationStenosis-RevascularizationThe report offers in-depth assessment of the growth and other aspects of the Neuroendovascular Coil market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.

)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Neuroendovascular Coil Market @ https://www.decisiondatabases.com/contact/download-sample-40676The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Neuroendovascular Coil product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Neuroendovascular Coil, with price, sales, revenue and global market share of Neuroendovascular Coil in 2018 and 2019.Chapter 3, the Neuroendovascular Coil competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Neuroendovascular Coil breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Neuroendovascular Coil market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Neuroendovascular Coil sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Neuroendovascular Coil Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-40676Other Reports by DecisionDatabases.com:Global Neuromyelitis Optica Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025Global Neurofeedback Market 2020 by Company, Regions, Type and Application, Forecast to 2025Global Neurological Biomarkers Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.

DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.

Common Warning Signs Of An Acute Ischemic Stroke You Should Never Ignore

MrMed Pharmacy 2024-11-25

What is an acute ischemic stroke? An acute ischemic stroke occurs when a blood clot or other blockage disrupts blood flow to a part of the brain. What are the signs of an acute ischemic stroke? How can you prevent an acute ischemic stroke? An acute ischemic stroke doesn’t announce itself - it strikes suddenly, leaving little room for error.

Stroke Disorder and Treatment Market Insights Share, Analysis, Trend, Size, Growth till 2027

nilesh 2022-05-03

It analyzes the market on the basis of various factors including porters five force analysis, price analysis, and supply chain analysis. com/sample_request/1651 The global stroke disorder and treatment market has been segmented into medicines, treatment, types, and lastly region. The regional segmentation of global stroke disorder and treatment market cover North America, Europe, and the Asia Pacific. com/reports/stroke-disorder-treatment-market-1651 About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Stroke Disorder and Treatment Market Size, Treatment, Medicine and forecast

anna grace 2022-02-14

com/sample_request/1651Stroke Disorder & Treatment Market SegmentationThe global Stroke Disorder and Treatment Market Size has been segmented into medicines, treatment, types, and lastly region. Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brainStroke Disorder & Treatment Market Regional AnalysisThe regional segmentation of global Stroke Disorder and Treatment Market Size cover North America, Europe, and the Asia Pacific. In other parts of the world, the market for stroke disorder and treatment is limited due to less advanced medical facilities, little investment in health care, lack of awareness about stroke disorder, and poor infrastructure. among others are some key companies in the global Stroke Disorder & Treatment that are listed by MRFR for market research. com

Ischemic stroke market size Top Market Segments Like Resin Type, Compound Type, Composite Type And End User

Market Research Future 2022-05-17

Prevalence of Diabetes Expected to Push the Demand for the Global Ischemic Stroke MarketIschemic Strokes occur when an artery or blood vessel supplying blood to the brain is blocked. As per the latest report released by Market Research Future (MRFR), the Global Ischemic stroke market size is expected to attain a CAGR of approximately 8. Regional Analysis The Global ischemic stroke Market is geographically segmented into the following regions: Asia Pacific, America, Europe, and the Middle East and Africa. About US:Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact us:Market Research Future (part of Wantstats Research and Media Private Limited),99 Hudson Street,5Th Floor, New York,New York 10013

Global Stroke Management Market Report 2024: Growth Rate, Major Segments And Regions

saikiran TBRC 2024-02-28

Learn More On The Stroke Management Market:https://www. The stroke management market size is expected to see strong growth in the next few years. The increasing incidence of chronic diseases is expected to propel the growth of the stroke management market going forward. Companies operating in the stroke management market are adopting new technologies to sustain their position in the market. The stroke management market report table of contents includes:1.

Cerebrolysin - Solution for Injection

RxEli 2021-07-22

- Cerebrolysin 10 x 2 ml- Cerebrolysin 5 x 5 ml- Cerebrolysin 5 x 10 ml Cerebrolysin is a neurometabolic stimulator based on neuropeptides (20 percent) and amino acids (80 percent) isolated from pig brain tissue.

It was developed in 1949 by Gerhart Harrer, an Austrian professor, and approved on August 1, 1954.

Used as a treatment for: - Strokes and complications associated with strokes- Depression, anxiety, and other brain diseases- Alzheimer's disease and other types of dementia- Traumatic brain injury and spinal cord injuries- ADHD in children Country of Manufacture: Austria Contraindications– individual intolerance to the drug– acute renal failure– status epilepticus Side effects– fever, sensation of heat (with rapid intravenous infusion)Rarely:– headache, dizziness– loss of appetite, nausea, vomiting, dyspepsia, diarrhea, constipation– allergic reactions: skin redness, itching and burning at the injection site Mode of applicationIt is used only parenterally: in the form of intramuscular injections (up to 5 ml), and intravenous infusions (10-60 ml), it is recommended to enter only by slow intravenous infusions after dilution with the proposed standard solutions for infusion.

Doses and duration of treatment depend on the nature and severity of the disease, as well as on the patient’s age.

The standard duration of treatment is 4 weeks (5 injections / infusions per week, preferably daily).To increase the effectiveness of treatment, repeated courses can be carried out until positive treatment results are obtained.

After the first course, the frequency of prescribing doses can be reduced to 2 or 3 times a week.In Alzheimer’s disease, dementia syndrome of various origins: intravenous infusion of 20-30 ml in 100-200 ml of saline, for a course of treatment 20 infusions, 5 infusions per week (followed by a 2-day break) for 28 days.